Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term use of alogliptin + metformin in elderly or renally/hepatically impaired type 2 diabetes mellitus patients
jRCT1080223922Completed
- Sponsor
- Takeda
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of alogliptin + metformin in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Jun 2018; status: completed.
02
Drugs
alogliptin + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080223922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223922.